ZVRA logo

ZVRA
Zevra Therapeutics Inc

23,982
Mkt Cap
$484.16M
Volume
604,340.00
52W High
$13.16
52W Low
$6.19
PE Ratio
13.63
ZVRA Fundamentals
Price
$8.60
Prev Close
$8.36
Open
$8.53
50D MA
$8.65
Beta
0.89
Avg. Volume
1.04M
EPS (Annual)
-$2.28
P/B
3.63
Rev/Employee
$400,203.39
Loading...
Loading...
News
all
press releases
Timothy Sangiovanni Sells 3,000 Shares of Zevra Therapeutics (NASDAQ:ZVRA) Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) SVP Timothy Sangiovanni sold 3,000 shares of the company's stock in a transaction dated Tuesday, February 3rd. The shares were sold at an...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Neil Mcfarlane Sells 91,000 Shares of Zevra Therapeutics (NASDAQ:ZVRA) Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) CEO Neil Mcfarlane sold 91,000 shares of the firm's stock in a transaction dated Monday, February 2nd. The stock was sold at an average price...
MarketBeat·4d ago
News Placeholder
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Rating of "Moderate Buy" from Analysts
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight analysts that are currently covering the stock, MarketBeat Ratings...
MarketBeat·7d ago
News Placeholder
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Short Interest Down 32.5% in January
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) saw a significant drop in short interest in January. As of January 15th, there was short interest totaling 3,991,736 shares, a drop of 32.5...
MarketBeat·7d ago
News Placeholder
Zevra Therapeutics (NASDAQ:ZVRA) Trading 5.2% Higher - Here's What Happened
Zevra Therapeutics (NASDAQ:ZVRA) Trading 5.2% Higher - What's Next...
MarketBeat·15d ago
News Placeholder
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Average Rating of "Moderate Buy" by Analysts
Shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) have been given an average rating of "Moderate Buy" by the eight analysts that are currently covering the company, MarketBeat...
MarketBeat·1mo ago
News Placeholder
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Given Average Recommendation of "Moderate Buy" by Brokerages
Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the eight analysts that are currently covering the stock, MarketBeat reports. One...
MarketBeat·2mo ago
News Placeholder
Zevra Therapeutics, Inc. $ZVRA Holdings Boosted by Stonepine Capital Management LLC
Stonepine Capital Management LLC boosted its stake in shares of Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) by 19.3% in the second quarter, according to the company in its most recent Form...
MarketBeat·2mo ago
News Placeholder
Zevra Therapeutics (NASDAQ:ZVRA) Trading Up 3.8% - Here's Why
Zevra Therapeutics (NASDAQ:ZVRA) Trading Up 3.8% - Should You Buy...
MarketBeat·3mo ago
News Placeholder
Campbell & CO Investment Adviser LLC Buys Shares of 83,245 Zevra Therapeutics, Inc. $ZVRA
Campbell & CO Investment Adviser LLC purchased a new position in Zevra Therapeutics, Inc. (NASDAQ:ZVRA - Free Report) in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·3mo ago
<
1
2
...
>

Latest ZVRA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.